Investor Relations

Overview

Corporate Profile

Through dedication and innovation, Second Sight's mission is to develop, manufacture and market implantable visual prosthetics to enable blind individuals to achieve greater independence.

Press Releases

Jul 5, 2017
Second Sight Announces Market Entry into South Korea with Two Implants and Performs Second Implant in Taiwan of Argus II Retinal Prosthesis System
Jul 3, 2017
Second Sight Announces Expansion of Medicare Coverage for Argus II Retinal Prosthesis System to 11 Additional States and the District of Columbia

View All >>

Events & Presentations

May 25, 2017 at 9:30 AM PT
18th Annual B. Riley & Co. Institutional Investor Conference
May 3, 2017 at 4:30 PM ET
Q1 2017 Financial Results Conference Call

View All >>

Stock Quote (EYES)

1.26 +0.01  (+0.808%)
Last updated: 12:58 PM ET on Jul 13, 2017
Previous Close 1.25
Open 1.24
Volume 37,151
Exchange NASDAQ
Day High 1.27
Day Low 1.23
52-Week High 4.50
52-Week Low 1.06